REPLICATION AND PATHOGENESIS OF ENVELOPED VIRUSES

有包膜病毒的复制和发病机制

基本信息

项目摘要

During the past year this study continued to focus on the role of the viral matrix protein M of vesicular stomatitis virus (VSV) in cytopathogenesis and in viral assembly. We had previously reported that the VSV M protein is responsible for cytopathic effects which involve the disorganization of the cytoskeleton after VSV infections. Other investigators also found that the matrix protein, which remains the only protein of this cytoplasmic virus found in cell nuclei is able to inhibit cellular transcription. We have studied this property of the M protein after isolation of HIV-1 susceptible cell clones which encode either a wild type or a temperature sensitive M protein under the control of the inducible HIV-1 LTR promoter. Cell clones which encode this protein were infected with HIV-1 as well as with HIV-2. Gene expression and replication of both viruses were drastically inhibited by wild type M protein after transactivation with the HIV Tat1 and Tat2 proteins, respectively. Although HIV-1 was able to establish a provirus in these cells at the same efficiency as in cells without M protein, subsequent viral gene expression and spread were drastically inhibited in M expressing cell lines. Since basal levels of wild type VSV M protein were not toxic to the cell, it appeared to function as an inducible antiviral. The mechanism for the inhibition of cellular transcription by the VSV M protein was further studied in the context of interferon inducible genes which are turned off after VSV infections. A novel nuclear DNA binding protein was detected in a gel shift assay after VSV infections. Binding was detected with a specific interferon stimulated response element sequence. In collaboration with Dr. Ozato's group, we found that the induction of this protein binding was dependent on VSV gene expression and replication. With one of our temperature M protein mutants, this binding was temperature sensitive, which indicated that the VSV M protein may play a role in that shift. Supershift experiments did not identify M protein as part of the DNA/protein complex itself. Further experiments are in progress to examine the potential role of M protein in inducing this new DNA binding activity as well as its role in the shut off of cellular transcription. These studies will allow important insights into the mechanism of VSV induced cytopathogenesis as well as into specific mechanisms of gene regulation, possibly involving new negative cellular transcription factors.
在过去的一年中,这项研究继续关注 囊泡口腔炎病毒(VSV)的病毒基质蛋白M 细胞病变和病毒组装中。我们以前曾报道过 VSV M蛋白负责涉及的细胞病毒作用 VSV感染后细胞骨架的混乱。其他 调查人员还发现,基质蛋白,它仍然是唯一的 在细胞核中发现的这种细胞质病毒的蛋白质能够抑制 细胞转录。我们研究了M蛋白的这种特性 分离出HIV-1易感细胞克隆后,该克隆编码A 野生型或温度敏感的M蛋白在控制下 诱导HIV-1 LTR启动子。编码该蛋白的细胞克隆是 感染HIV-1以及HIV-2。基因表达和 两种病毒的复制受到野生型M的巨大抑制 与HIV Tat1和Tat2蛋白反式激活后的蛋白质, 分别。尽管HIV-1能够在这些 细胞的效率与没有M蛋白的细胞相同,随后 病毒基因表达和扩散在M中得到了巨大抑制 表达细胞系。由于野生型VSV M蛋白的基础水平为 对细胞无毒,它似乎是诱导型抗病毒。 VSV M抑制细胞转录的机制 在干扰素诱导基因的背景下进一步研究了蛋白质 在VSV感染后将关闭。 一种新型的核DNA结合 VSV感染后,在凝胶转移测定中检测到蛋白质。结合 用特定的干扰素刺激响应元件检测到 顺序。与Ozato博士的小组合作,我们发现 该蛋白结合的诱导取决于VSV基因表达 和复制。使用我们的温度M蛋白突变体之一, 结合对温度敏感,这表明VSV M蛋白 可能在这一转变中发挥作用。 Supershift实验未识别 M蛋白作为DNA/蛋白质复合物本身的一部分。进一步的实验 正在进行研究M蛋白在诱导中的潜在作用 这种新的DNA结合活性以及其在关闭中的作用 细胞转录。这些研究将允许对 VSV的机制诱导了细胞病生成以及特定的 基因调节的机制,可能涉及新的阴性细胞 转录因子。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

M SCHUBERT其他文献

M SCHUBERT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('M SCHUBERT', 18)}}的其他基金

PSEUDOTYPIC DEFECTIVE INTERFERING HIV PARTICLES AS AN ANTIVIRAL THERAPY FOR AIDS
假型缺陷干扰 HIV 颗粒作为艾滋病抗病毒疗法
  • 批准号:
    6163049
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PSEUDOTYPIC DEFECTIVE INTERFERING HIV PARTICLES AS AN ANTIVIRAL THERAPY FOR AIDS
假型缺陷干扰 HIV 颗粒作为艾滋病抗病毒疗法
  • 批准号:
    2579598
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MULTITARGET RIBOZYMES AS ANALYTICAL AND THERAPEUTIC AGENTS
多靶点核酶作为分析剂和治疗剂
  • 批准号:
    2579665
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REPLICATION AND PATHOGENESIS OF ENVELOPED VIRUSES
有包膜病毒的复制和发病机制
  • 批准号:
    3881817
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MULTITARGET RIBOZYMES AS ANALYTICAL AND THERAPEUTIC AGENTS
多靶点核酶作为分析剂和治疗剂
  • 批准号:
    5204025
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REPLICATION AND PATHOGENESIS OF ENVELOPED VIRUSES
有包膜病毒的复制和发病机制
  • 批准号:
    6163043
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ORAL TOXICITY/ COMPLICATIONS FOLLOWING BONE MARROW TRANSPLANTS
骨髓移植后的口腔毒性/并发症
  • 批准号:
    3795007
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REPLICATION AND PATHOGENESIS OF ENVELOPED VIRUSES
有包膜病毒的复制和发病机制
  • 批准号:
    3782381
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PSEUDOTYPIC DEFECTIVE INTERFERING HIV PARTICLES AS AN ANTIVIRAL THERAPY FOR AIDS
假型缺陷干扰 HIV 颗粒作为艾滋病抗病毒疗法
  • 批准号:
    3782407
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ORAL TOXICITY/ COMPLICATIONS FOLLOWING BONE MARROW TRANSPLANTS
骨髓移植后的口腔毒性/并发症
  • 批准号:
    3772762
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

烟芽夜蛾囊泡病毒3h毒株(HvAV-3h)调控斜纹夜蛾幼虫寄主选择行为机制研究
  • 批准号:
    32172408
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
烟芽夜蛾囊泡病毒3h株干扰宿主细胞周期的分子机制
  • 批准号:
    31872027
  • 批准年份:
    2018
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目
囊泡病毒调控媒介寄生蜂的寄主选择识别机制研究
  • 批准号:
    31801799
  • 批准年份:
    2018
  • 资助金额:
    26.0 万元
  • 项目类别:
    青年科学基金项目
烟芽夜蛾囊泡病毒3h株对甜菜夜蛾脂肪体细胞的抗凋亡反应机制
  • 批准号:
    31700141
  • 批准年份:
    2017
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
高致病性囊泡病毒HvAV-3h的DNA复制、演化及其传播机制研究
  • 批准号:
    31371995
  • 批准年份:
    2013
  • 资助金额:
    78.0 万元
  • 项目类别:
    面上项目
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了